Download PDF
CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd 2023; 83(12): 1431-1445
DOI: 10.1055/a-2111-7394
GebFra Science
Statement/Stellungnahme

Toxoplasma-gondii-Infektion in der Schwangerschaft – Empfehlungen der Arbeitsgemeinschaft Geburtshilfe und Pränatalmedizin (AGG – Sektion Maternale Erkrankungen)

Article in several languages: English | deutsch
Michael Oliver Schneider
1   Department of Gynaecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
,
Florian Faschingbauer
1   Department of Gynaecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
,
Karl Oliver Kagan
2   Department for Womenʼs Health, University Hospital of Tübingen, Tübingen, Germany
,
Uwe Groß
3   Institute of Medical Microbiology and Virology, University Medical Centre Göttingen, Göttingen, Germany
,
Martin Enders
4   Laboratory Prof. Gisela Enders and Colleagues, Stuttgart, Germany
,
Sven Kehl
1   Department of Gynaecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
,
for the AGG Section Maternal Diseases › Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Zusammenfassung

Ziel Diese Empfehlungen der AGG (Arbeitsgemeinschaft für Geburtshilfe und Pränatalmedizin, Sektion maternale Erkrankungen) haben das Ziel der Verbesserung der Diagnostik und des Managements von Toxoplasma-gondii-Infektionen in der Schwangerschaft.

Methoden Basierend auf der aktuellen Literatur entwickelten die Mitglieder der Task Force die vorliegenden Empfehlungen und Stellungnahmen. Diese Empfehlungen wurden nach einem Konsens der Mitglieder der Arbeitsgruppe verabschiedet.

Empfehlungen Das folgende Manuskript beschäftigt sich mit der Epidemiologie und Pathophysiologie von Toxoplasma-gondii-Infektionen in der Schwangerschaft und enthält Empfehlungen zu maternaler und fetaler Diagnostik, Transmissionsprophylaxe, Therapie, Prävention, Screening und peripartalem Management.

Schlüsselwörter

Schwangerschaft - Toxoplasmose - Diagnostik - Transmissionsprophylaxe - Therapie


Publication History

Received: 14 June 2023

Accepted after revision: 18 July 2023

Article published online:
18 September 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References/Literatur

  • 1 Robert Koch-Institut. RKI-Ratgeber Toxoplasmose. Epidemiol Bull 2018; 42: 451-460
    PubMedSearch in Google Scholar
  • 2 Wilking H, Thamm M, Stark K. et al. Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep 2016; 6: 22551
    CrossrefPubMedSearch in Google Scholar
  • 3 Pleyer U, Groß U, Schlüter D. et al. Toxoplasmosis in Germany: Epidemiology, Diagnosis, Risk Factors, and Treatment. Dtsch Arztebl Int 2019; 116: 435-444
    CrossrefPubMedSearch in Google Scholar
  • 4 Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976
    CrossrefPubMedSearch in Google Scholar
  • 5 Beringer T. [Is diagnosis of toxoplasmosis within the scope of prenatal care meaningful?]. Geburtshilfe Frauenheilkd 1992; 52: 740-741
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Krings A, Jacob J, Seeber F. et al. Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011–2016. Emerg Infect Dis 2021; 27: 2097-2106
    CrossrefPubMedSearch in Google Scholar
  • 7 Prusa A-R, Kasper DC, Pollak A. et al. The Austrian Toxoplasmosis Register, 1992–2008. Clin Infect Dis 2015; 60: e4-e10
    CrossrefPubMedSearch in Google Scholar
  • 8 Paquet C, Yudin MH. No. 285-Toxoplasmosis in Pregnancy: Prevention, Screening, and Treatment. J Obstet Gynaecol Can 2018; 40: e687-e693
    CrossrefPubMedSearch in Google Scholar
  • 9 Leruez-Ville M, Benoist G, Ville Y. Fetal Infections: Clinical Management. In: Kilby MD, Johnson A, Oepkes D, eds. Fetal Therapy. Cambridge University Press; 2019: 224-247
    Search in Google Scholar
  • 10 Hotop A, Hlobil H, Gross U. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2012; 54: 1545-1552
    CrossrefPubMedSearch in Google Scholar
  • 11 Dubey JP, Murata FHA, Cerqueira-Cézar CK. et al. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitology 2021; 148: 1406-1416
    CrossrefPubMedSearch in Google Scholar
  • 12 Picone O, Fuchs F, Benoist G. et al. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF. J Gynecol Obstet Hum Reprod 2020; 49: 101814
    CrossrefPubMedSearch in Google Scholar
  • 13 Codaccioni C, Picone O, Lambert V. et al. Ultrasound features of fetal toxoplasmosis: A contemporary multicenter survey in 88 fetuses. Prenat Diagn 2020; 40: 1741-1752
    CrossrefPubMedSearch in Google Scholar
  • 14 Kieffer F, Wallon M, Garcia P. et al. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J 2008; 27: 27-32
    CrossrefPubMedSearch in Google Scholar
  • 15 SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Thiébaut R, Leproust S. et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patientsʼ data. Lancet 2007; 369: 115-122
    CrossrefPubMedSearch in Google Scholar
  • 16 Berrébi A, Assouline C, Bessières M-H. et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol 2010; 203: 552.e1-552.e6
    CrossrefPubMedSearch in Google Scholar
  • 17 Dunn D, Wallon M, Peyron F. et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829-1833
    CrossrefPubMedSearch in Google Scholar
  • 18 Wallon M, Peyron F, Cornu C. et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis 2013; 56: 1223-1231
    CrossrefPubMedSearch in Google Scholar
  • 19 Gilbert RE, Freeman K, Lago EG. et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2008; 2: e277
    CrossrefPubMedSearch in Google Scholar
  • 20 Tan HK, Schmidt D, Stanford M. et al. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am J Ophthalmol 2007; 144: 648-653
    CrossrefPubMedSearch in Google Scholar
  • 21 Wallon M, Kodjikian L, Binquet C. et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004; 113: 1567-1572
    CrossrefPubMedSearch in Google Scholar
  • 22 Peyron F, Garweg JG, Wallon M. et al. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis J 2011; 30: 597-600
    CrossrefPubMedSearch in Google Scholar
  • 23 Roizen N, Kasza K, Karrison T. et al. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics 2006; 118: e379-e390
    CrossrefPubMedSearch in Google Scholar
  • 24 Eichenwald HF. A study of congenital toxoplasmosis, with particular emphasis on clinical manifestations, sequelae and therapy. In: Siim JC. ed. Human toxoplasmosis. Copenhagen: Munksgaard; 1960: 41-49
    Search in Google Scholar
  • 25 Hutson SL, Wheeler KM, McLone D. et al. Patterns of Hydrocephalus Caused by Congenital Toxoplasma gondii Infection Associate With Parasite Genetics. Clin Infect Dis 2015; 61: 1831-1834
    CrossrefPubMedSearch in Google Scholar
  • 26 McLone D, Frim D, Penn R. et al. Outcomes of hydrocephalus secondary to congenital toxoplasmosis. J Neurosurg Pediatr 2019;
    CrossrefPubMedSearch in Google Scholar
  • 27 Anand R, Jones CW, Ricks JH. et al. Acute primary toxoplasmosis in travelers returning from endemic countries. J Travel Med 2012; 19: 57-60
    CrossrefPubMedSearch in Google Scholar
  • 28 Rudzinski M, Khoury M, Couto C. et al. Reactivation of Ocular Toxoplasmosis in Non-Hispanic Persons, Misiones Province, Argentina. Emerg Infect Dis 2016; 22: 912-913
    CrossrefPubMedSearch in Google Scholar
  • 29 Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008; 47: 554-566
    CrossrefPubMedSearch in Google Scholar
  • 30 Fricker-Hidalgo H, Cimon B, Chemla C. et al. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study. J Clin Microbiol 2013; 51: 2103-2111
    CrossrefPubMedSearch in Google Scholar
  • 31 Elbez-Rubinstein A, Ajzenberg D, Dardé M-L. et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 2009; 199: 280-285
    CrossrefPubMedSearch in Google Scholar
  • 32 Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. European Collaborative Study and Research Network on Congenital Toxoplasmosis. Eur J Obstet Gynecol Reprod Biol 1996; 68: 93-96
    CrossrefPubMedSearch in Google Scholar
  • 33 Liesenfeld O, Montoya JG, Tathineni NJ. et al. Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol 2001; 184: 140-145
    CrossrefPubMedSearch in Google Scholar
  • 34 Maldonado YA, Read JS. COMMITTEE ON INFECTIOUS DISEASES. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics 2017; 139: e20163860
    CrossrefPubMedSearch in Google Scholar
  • 35 Peyron F, Lʼollivier C, Mandelbrot L. et al. Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group. Pathogens 2019; 8: 24
    CrossrefPubMedSearch in Google Scholar
  • 36 Khalil A, Sotiriadis A, Chaoui R. et al. ISUOG Practice Guidelines: role of ultrasound in congenital infection. Ultrasound Obstet Gynecol 2020; 56: 128-151
    CrossrefPubMedSearch in Google Scholar
  • 37 de Oliveira Azevedo CT, do Brasil PEAA, Guida L. et al. Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis. PloS One 2016; 11: e0149938
    CrossrefPubMedSearch in Google Scholar
  • 38 Sterkers Y, Pratlong F, Albaba S. et al. Novel Interpretation of Molecular Diagnosis of Congenital Toxoplasmosis According to Gestational Age at the Time of Maternal Infection. J Clin Microbiol 2012; 50: 3944-3951
    CrossrefPubMedSearch in Google Scholar
  • 39 Wallon M, Franck J, Thulliez P. et al. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet Gynecol 2010; 115: 727-733
    CrossrefPubMedSearch in Google Scholar
  • 40 Rabilloud M, Wallon M, Peyron F. In utero and at birth diagnosis of congenital toxoplasmosis: use of likelihood ratios for clinical management. Pediatr Infect Dis J 2010; 29: 421-425
    CrossrefPubMedSearch in Google Scholar
  • 41 Thalib L, Gras L, Romand S. et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG Int J Obstet Gynaecol 2005; 112: 567-574
    CrossrefPubMedSearch in Google Scholar
  • 42 Prusa A-R, Kasper DC, Pollak A. et al. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clin Microbiol Infect 2015; 21: 191.e1-191.e8
    CrossrefPubMedSearch in Google Scholar
  • 43 Salomon LJ, Sotiriadis A, Wulff CB. et al. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol 2019; 54: 442-451
    CrossrefPubMedSearch in Google Scholar
  • 44 Patel DV, Holfels EM, Vogel NP. et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology 1996; 199: 433-440
    CrossrefPubMedSearch in Google Scholar
  • 45 Blondiaux E, Garel C. Fetal cerebral imaging – ultrasound vs. MRI: an update. Acta Radiol 2013; 54: 1046-1054
    CrossrefPubMedSearch in Google Scholar
  • 46 Berrebi A, Bardou M, Bessieres M-H. et al. Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases. Eur J Obstet Gynecol Reprod Biol 2007; 135: 53-57
    CrossrefPubMedSearch in Google Scholar
  • 47 Mandelbrot L, Kieffer F, Wallon M. et al. Toxoplasmose pendant la grossesse: proposition actuelle de prise en charge pratique. Gynecol Obstet Fertil Senol 2021; 49: 782-791
    CrossrefPubMedSearch in Google Scholar
  • 48 Di Mascio D, Rizzo G, Khalil A. et al. Role of fetal magnetic resonance imaging in fetuses with congenital cytomegalovirus infection: multicenter study. Ultrasound Obstet Gynecol 2023; 61: 67-73
    CrossrefPubMedSearch in Google Scholar
  • 49 Mandelbrot L, Kieffer F, Sitta R. et al. Prenatal therapy with pyrimethamine + sulfadiazine vs. spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Am J Obstet Gynecol 2018; 219: 386.e1-386.e9
    CrossrefPubMedSearch in Google Scholar
  • 50 Schoondermark-van de Ven EM, Melchers WJ, Galama JM. et al. Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys. Eur J Obstet Gynecol Reprod Biol 1997; 74: 183-188
    CrossrefPubMedSearch in Google Scholar
  • 51 Cortina-Borja M, Tan HK, Wallon M. et al. Prenatal Treatment for Serious Neurological Sequelae of Congenital Toxoplasmosis: An Observational Prospective Cohort Study. PLoS Med 2010; 7: 11
    CrossrefPubMedSearch in Google Scholar
  • 52 Gras L, Wallon M, Pollak A. et al. European Multicenter Study on Congenital Toxoplasmosis. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 2005; 94: 1721-1731
    CrossrefPubMedSearch in Google Scholar
  • 53 Schuster S, Janatzek S, Chittka L. IGeLMonitor- Evidenz ausführlich – Toxoplasmose-Test in der Schwangerschaft. Accessed September 10, 2022 at: https://www.igel-monitor.de/fileadmin/user_upload/Toxoplasmosetest_Schwangerschaft_Evidenz_ausfuehrlich.pdf
    PubMed
  • 54 Katlama C, De Wit S, OʼDoherty E. et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996; 22: 268-275
    CrossrefPubMedSearch in Google Scholar
  • 55 Araujo FG, Remington JS. Effect of Clindamycin on Acute and Chronic Toxoplasmosis in Mice. Antimicrob Agents Chemother 1974; 5: 647-651
    CrossrefPubMedSearch in Google Scholar
  • 56 Buonsenso D, Pata D, Turriziani Colonna A. et al. Spyramicine and Trimethoprim-Sulfamethoxazole Combination to Prevent Mother-To-Fetus Transmission of Toxoplasma gondii Infection in Pregnant Women: A 28-Years Single-center Experience. Pediatr Infect Dis J 2022; 41: e223-e227
    CrossrefPubMedSearch in Google Scholar
  • 57 EACSociety. EACS Guidelines. Accessed September 17, 2022 at: https://www.eacsociety.org/guidelines/eacs-guidelines/
    PubMed
  • 58 Reiter-Owona I, Hlobil H, Enders M. et al. Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study. Eur J Med Res 2020; 25: 59
    CrossrefPubMedSearch in Google Scholar
  • 59 Peytavin G, Leng JJ, Forestier F. et al. Placental transfer of pyrimethamine studied in an ex vivo placental perfusion model. Biol Neonate 2000; 78: 83-85
    CrossrefPubMedSearch in Google Scholar
  • 60 Wehbe K, Pencole L, Lhuaire M. et al. Hygiene measures as primary prevention of toxoplasmosis during pregnancy: A systematic review. J Gynecol Obstet Hum Reprod 2022; 51: 102300
    CrossrefPubMedSearch in Google Scholar
  • 61 Gemeinsamer Bundesausschuss. Mutterschafts-Richtlinien. 2021. Accessed April 18, 2023 at: https://www.g-ba.de/downloads/62-492-2676/Mu-RL_2021-09-16_iK-2022-01-01.pdf
    PubMed
  • 62 Prusa A-R, Kasper DC, Sawers L. et al. Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving. PLoS Negl Trop Dis 2017; 11: e0005648
    CrossrefPubMedSearch in Google Scholar
  • 63 SGGG. Expertenbrief 31 – Verzicht auf das Toxoplasmose-Screening in der Schwangerschaft – kurze zusammenfassende Begründung. 2010. Accessed September 17, 2022 at: https://www.sggg.ch/fileadmin/user_upload/PDF/31_Toxoplasmose-Screening_2010.pdf
    PubMed
  • 64 Wallon M, Kieffer F, Huissoud C. et al. Cesarean delivery or induction of labor does not prevent vertical transmission of toxoplasmosis in late pregnancy. Int J Gynaecol Obstet 2015; 129: 176-177
    CrossrefPubMedSearch in Google Scholar
  • 65 Arbeitsgruppe Infektiologie der Österreichischen Gesellschaft für Kinderheilkunde. Österreichische Richtlinie für das Toxoplasmose-Screening in der Schwangerschaft und frühen Kindheit. 2013. Accessed January 21, 2021 at: https://www.oeghmp.at/media/richtlinie_toxoplasmose-screening.pdf
    PubMed
  • 66 Wichtige humane Parasitosen: Toxoplasmose. Z Gastroenterol 2020; 58: 742-746
    Thieme ConnectPubMedSearch in Google Scholar